Cloning of Seel-renewal factor receptors from hemopoietic stem cells
造血干细胞 Seel 更新因子受体的克隆
基本信息
- 批准号:05454333
- 负责人:
- 金额:$ 4.35万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Receptor and cytoplasmic tyrosine kinases essential functions in the hematopoietic cell development and signal transduction. In this project, we have characterized novel receptor tyrosine kinases, STK and TIE which are expresed in hematopoietic cells.STK encodes a 1,378 amino acid protein. STK was expressed in a various stage of hematopoietic cells including cells, but ont apparent expression in other adult tissues. We recently confirmed that STK prtein was phosphorylated by the binding of macrophage stimulating factor (MSP) of HGF-like protein (HLP) . As is the case in HGF/c-MET system, MSP/STK system is functional in hematopoietic cells. We have shown that MSP/STK play a role in the differentiation of macrophages and erythroid cells.TIE is unclassified RTK which is expressed in megakaryocytes and stem cells as well as endothelial cells. The amino acid homology between murine TIE and TEK was 46.2% in total. They shared a unique structural prperty of coexistent immunoglobulin-like domain, epidermal growth factor-like repeats, and fibronectin type lll repeats in their extracellular domains. The mouse TIE and TEK genes are located very close in chromosome4. This is syntenic to human chromosome region, 1p34 and 9p21, where the human TIE and TEK gene are mapped, respectively. Thus, TIE and TEK are tow linked members of a gene. Flow cytomery shows that TIE is mainly expressed in the fraction of CD34-positive of c-kit-positive cells. lt is interesting that TIE and TEK are expressed in both endothelial cells and hematopoietic stem cells, since both cells are thought to originate from the same progenitor cells. We hope that characterization of these kinases will be helpful to elucidate the molecular mechanism of the growth regulation of hematopoietic stem cells.
受体和细胞质酪氨酸激酶在造血细胞发育和信号转导中发挥重要作用。在这个项目中,我们鉴定了在造血细胞中表达的新型受体酪氨酸激酶 STK 和 TIE。STK 编码 1,378 个氨基酸的蛋白质。 STK在包括细胞在内的各个阶段的造血细胞中表达,但在其他成体组织中表达不明显。我们最近证实STK蛋白通过与HGF样蛋白(HLP)的巨噬细胞刺激因子(MSP)的结合而被磷酸化。与HGF/c-MET系统的情况一样,MSP/STK系统在造血细胞中发挥功能。我们已经证明MSP/STK在巨噬细胞和红系细胞的分化中发挥作用。TIE是未分类的RTK,在巨核细胞、干细胞以及内皮细胞中表达。小鼠TIE与TEK的氨基酸同源性总计为46.2%。它们在胞外域中具有共存的免疫球蛋白样结构域、表皮生长因子样重复序列和纤连蛋白III型重复序列的独特结构特性。小鼠 TIE 和 TEK 基因位于第 4 号染色体上非常接近。这与人类染色体区域 1p34 和 9p21 是同线性的,人类 TIE 和 TEK 基因分别位于此处。因此,TIE 和 TEK 是基因的两个连锁成员。流式细胞术显示TIE主要表达于c-kit阳性细胞中CD34阳性部分。有趣的是,TIE 和 TEK 在内皮细胞和造血干细胞中均表达,因为这两种细胞被认为源自相同的祖细胞。我们希望这些激酶的表征将有助于阐明造血干细胞生长调节的分子机制。
项目成果
期刊论文数量(92)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gunji Y et al: "Human primitive hemopoietic progenitor cells are more enriched in KIT^<low> cells than KIT^<high> cells" Blood. 82. 3283-3289 (1993)
Gunji Y 等人:“人类原始造血祖细胞中 KIT^<低> 细胞比 KIT^<高> 细胞更丰富” 血液。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Muroi K et all: "Expression of sialyl-Lewis^x in CD34-positivel eukemic blasts" Leukemia. 7. 336-337 (1993)
Muroi K 等人:“CD34 阳性白血病细胞中唾液酸-Lewis^x 的表达”白血病。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
lwama A et al: "Molecular cloning of a novel receptor tyrosine kinase gene, STK,derived from enriched hematopoietic stem cells" Blood. 83. 3160-3169 (1994)
lwama A 等人:“源自富集造血干细胞的新型受体酪氨酸激酶基因 STK 的分子克隆”血液。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sakano Set al: "Molecular cloning of a novel non-receptor tyrosine kinase, HYL (hematopoietic concersus tyrosine-lacking kinase)" Oncogene. 9. 1155-1161 (1994)
Sakano Set al:“新型非受体酪氨酸激酶 HYL(造血细胞酪氨酸缺乏激酶)的分子克隆”癌基因。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
lto A et al: "Enhanced expression of stem cell antigen, CD34 messenger RNA developing endothelial cells" Labo.lnvest. (in press). (1995)
lto A 等人:“增强干细胞抗原、CD34 信使 RNA 发育内皮细胞的表达”Labo.Invest。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUDA Toshio其他文献
SUDA Toshio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUDA Toshio', 18)}}的其他基金
Self-renewal capacity of hematopoietic stem cells and mitochondrial metabolism
造血干细胞的自我更新能力与线粒体代谢
- 批准号:
18H05284 - 财政年份:2018
- 资助金额:
$ 4.35万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Homeostasis of hematopoietic stem cells and its breakdown
造血干细胞的稳态及其分解
- 批准号:
26221309 - 财政年份:2014
- 资助金额:
$ 4.35万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Nicher Regulation for Normal Hemopoietic Stem Cells and Leukemic Stem Cells
正常造血干细胞和白血病干细胞的利基调节
- 批准号:
23249053 - 财政年份:2011
- 资助金额:
$ 4.35万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Regulation of Hematopoietic Stem Cell Division in a Niche
微环境中造血干细胞分裂的调节
- 批准号:
16002011 - 财政年份:2004
- 资助金额:
$ 4.35万 - 项目类别:
Grant-in-Aid for Specially Promoted Research
Differentiation of Mesenchymal Stem Cells in Bone Marrow
骨髓间充质干细胞的分化
- 批准号:
12557082 - 财政年份:2000
- 资助金额:
$ 4.35万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular analysis for microenvironment of hematopoietic cells.
造血细胞微环境的分子分析。
- 批准号:
10307024 - 财政年份:1998
- 资助金额:
$ 4.35万 - 项目类别:
Grant-in-Aid for Scientific Research (A).
Self Renew and Cell Differentiation in Hemopoietic System
造血系统的自我更新和细胞分化
- 批准号:
10181103 - 财政年份:1998
- 资助金额:
$ 4.35万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Cloning and functional analysis of specific molecules of osteoclast
破骨细胞特定分子的克隆及功能分析
- 批准号:
09557086 - 财政年份:1997
- 资助金额:
$ 4.35万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional analyzes for common receptor tyrosine kinases of hematopoietic stem cells and vascular endothelial cells
造血干细胞和血管内皮细胞共同受体酪氨酸激酶的功能分析
- 批准号:
08457279 - 财政年份:1996
- 资助金额:
$ 4.35万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Purification and ampliefication of hematopoietic stem cells
造血干细胞的纯化和扩增
- 批准号:
06277104 - 财政年份:1994
- 资助金额:
$ 4.35万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
相似国自然基金
OTUD1调控RIPK1去泛素化修饰在内皮细胞炎性损伤介导的放射后脑微循环灌注障碍中的机制研究
- 批准号:82301568
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肝窦内皮细胞中DNASE1L3表达缺失在肝癌免疫抑制微环境形成中的作用机制
- 批准号:82372902
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
血管内皮细胞Mg2+/Mn2+依赖性蛋白磷酸酶1D基因突变在缺血性脑血管病中的作用机制研究
- 批准号:82371324
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
循环外泌体mtDNA调控内皮细胞铁死亡抑制糖尿病皮肤缺损愈合的机制研究
- 批准号:82301027
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Resolving the Role of Brain Lymphatic Endothelial Cells in Sleep Dependent Brain Clearance
解决脑淋巴内皮细胞在睡眠依赖性脑清除中的作用
- 批准号:
BB/Y001206/1 - 财政年份:2024
- 资助金额:
$ 4.35万 - 项目类别:
Research Grant
Microfluidics to explore the uptake of nanoparticles by endothelial cells
微流体技术探索内皮细胞对纳米粒子的摄取
- 批准号:
DP240101579 - 财政年份:2024
- 资助金额:
$ 4.35万 - 项目类别:
Discovery Projects
CAREER: Predictive Multiscale Modeling of Cell Migration through Pores between Endothelial Cells
职业:通过内皮细胞之间的孔进行细胞迁移的预测多尺度建模
- 批准号:
2339054 - 财政年份:2024
- 资助金额:
$ 4.35万 - 项目类别:
Standard Grant
Contribution of Endothelial Planar Cell Polarity pathways in Blood Flow Direction Sensing
内皮平面细胞极性通路在血流方向传感中的贡献
- 批准号:
10750690 - 财政年份:2024
- 资助金额:
$ 4.35万 - 项目类别:
Strategies for next-generation flavivirus vaccine development
下一代黄病毒疫苗开发策略
- 批准号:
10751480 - 财政年份:2024
- 资助金额:
$ 4.35万 - 项目类别: